Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05861778
Status:
COMPLETED
Last Update Posted:
2023-12-11
First Post:
2023-04-05
Brief Title:
Evaluation of 89Zr-TLX250 PETCT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma
Sponsor:
Telix Pharmaceuticals Innovations Pty Limited
Organization:
Telix Pharmaceuticals Innovations Pty Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-27
Completion Date Type:
ACTUAL
First Submit Date:
2023-04-05
First Submit QC Date:
May 14 2023
Study First Post Date:
2023-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-07
Last Update Post Date:
2023-12-11
Last Update Post Date Type:
ACTUAL